HarmonyFidelisHarmonyFidelis
登录
新闻重大项目主要机构学院
返回参与者列表

参与者简介 / 公司

Neuralink

Neuralink Corp.

使命 : Pioneering brain-computer interfaces to restore autonomy and communication.

简介来源与文献

AI生成的领域概念图,并非该机构或其设施的照片。

成立于
2016
总部
United States
状态
活跃

技术与贡献

Neurotechnology company developing an implantable brain-computer interface. Its clinical studies assess the safety and function of the N1 implant and R1 surgical robot, followed by their use to control assistive devices or restore communication.

部分旧有编辑内容仅有法文或英文版本。

技术与应用

  • Brain-computer interfaces
  • N1 implant
  • R1 surgical robot
  • Assistive technologies
  • Early-stage clinical trials

发展与当前工作

里程碑按时间排序,间距不代表时间长度。未来日期为已公布的目标。

  1. 2024

    PRIME: feasibility study in people with tetraplegia

    进行中

    Early-stage clinical study still recruiting in January 2026. It primarily assesses the clinical safety and function of the wireless, rechargeable N1 implant, placed by the R1 robot to enable control of external devices.

    [2]
  2. 2024

    CONVOY: control of assistive devices

    进行中

    Invitation-only study for PRIME participants. It assesses the feasibility, consistency and safety of neural control of a robotic arm and other assistive devices.

    [3]
  3. 2025

    VOICE: restoring communication

    进行中

    Recruiting early-stage study assessing the initial safety and effectiveness of the N1 and R1 systems for communication in adults with severe, irreversible speech-production impairment.

    [4]

参与的生态系统

生物技术与合成生物学

组织与相关资料

法律身份

法定名称
Neuralink Corp.
状态
活跃
核验日期
2026-08-30
下次复核
2026-11-30
Neuralink Corp.

来源与文献

每份参考资料均与其支持的论述关联。机构文献描述其自身工作,不构成独立验证。

  1. 01

    Official organization website

    Neuralink Corp.

    核验日期 2026-08-30

  2. 02

    PRIME: feasibility study in people with tetraplegia

    clinicaltrials.gov

    核验日期 2026-08-25

  3. 03

    CONVOY: control of assistive devices

    clinicaltrials.gov

    核验日期 2026-08-25

  4. 04

    VOICE: restoring communication

    clinicaltrials.gov

    核验日期 2026-08-25

  5. 05

    Neuralink clinical trials

    neuralink.com